EXV4.DE vs. SPYH.DE
Compare and contrast key facts about iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE) and SPDR MSCI Europe Health Care UCITS ETF (SPYH.DE).
EXV4.DE and SPYH.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. EXV4.DE is a passively managed fund by iShares that tracks the performance of the STOXX® Europe 600 Health Care. It was launched on Apr 25, 2001. SPYH.DE is a passively managed fund by State Street that tracks the performance of the MSCI Europe Health Care 20/35 Capped. It was launched on Dec 5, 2014. Both EXV4.DE and SPYH.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EXV4.DE or SPYH.DE.
Key characteristics
EXV4.DE | SPYH.DE | |
---|---|---|
YTD Return | 9.07% | 9.00% |
1Y Return | 12.61% | 12.28% |
3Y Return (Ann) | 3.76% | 4.52% |
5Y Return (Ann) | 7.11% | 7.67% |
10Y Return (Ann) | 7.00% | 6.78% |
Sharpe Ratio | 1.09 | 1.06 |
Sortino Ratio | 1.57 | 1.52 |
Omega Ratio | 1.19 | 1.19 |
Calmar Ratio | 1.11 | 1.09 |
Martin Ratio | 4.11 | 3.96 |
Ulcer Index | 3.16% | 3.28% |
Daily Std Dev | 11.91% | 12.24% |
Max Drawdown | -44.54% | -25.71% |
Current Drawdown | -11.16% | -11.45% |
Correlation
The correlation between EXV4.DE and SPYH.DE is 0.98, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
EXV4.DE vs. SPYH.DE - Performance Comparison
The year-to-date returns for both stocks are quite close, with EXV4.DE having a 9.07% return and SPYH.DE slightly lower at 9.00%. Both investments have delivered pretty close results over the past 10 years, with EXV4.DE having a 7.00% annualized return and SPYH.DE not far behind at 6.78%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
EXV4.DE vs. SPYH.DE - Expense Ratio Comparison
EXV4.DE has a 0.46% expense ratio, which is higher than SPYH.DE's 0.18% expense ratio.
Risk-Adjusted Performance
EXV4.DE vs. SPYH.DE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE) and SPDR MSCI Europe Health Care UCITS ETF (SPYH.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
EXV4.DE vs. SPYH.DE - Dividend Comparison
EXV4.DE's dividend yield for the trailing twelve months is around 1.38%, while SPYH.DE has not paid dividends to shareholders.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 1.38% | 1.60% | 1.59% | 1.47% | 1.24% | 1.79% | 1.85% | 2.64% | 2.90% | 2.60% | 2.36% | 2.39% |
SPDR MSCI Europe Health Care UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
EXV4.DE vs. SPYH.DE - Drawdown Comparison
The maximum EXV4.DE drawdown since its inception was -44.54%, which is greater than SPYH.DE's maximum drawdown of -25.71%. Use the drawdown chart below to compare losses from any high point for EXV4.DE and SPYH.DE. For additional features, visit the drawdowns tool.
Volatility
EXV4.DE vs. SPYH.DE - Volatility Comparison
iShares STOXX Europe 600 Health Care UCITS ETF (DE) (EXV4.DE) and SPDR MSCI Europe Health Care UCITS ETF (SPYH.DE) have volatilities of 3.27% and 3.21%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.